Home ADNKronos Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs
 

Immediapress

Novadip Biosciences SA announces significant clinical milestones for both of its clinical-stage programs

 

(Adnkronos) - 1st US patient treated with an autologous cell-based product (NVD-003) in a rare pediatric disease Full enrollment of patients on track for year-end completion in allogeneic cell-derived product (NVD-X3) trial in patients with a distal rad

I contenuti di VeneziePost sono a pagamento.
Per visualizzare questo articolo e tutti i nostri contenuti scegli tra queste opzioni
Sei già iscritto a VeneziePost?
Clicca qui sotto e inserisci le tue credenziali
Accedi
Facebook Twitter Linkedin Email